iRhythm Technologies (Nasdaq:IRTC) announced today that it appointed a new chief financial officer and a new chief human resources officer.
The San Francisco-based wearable electrocardiogram monitors developer will bring in Brice Bobzien as CFO and Reyna Fernandez as EVP and chief human resources officer (CHRO). Fernandez’s appointment was made effective today, while Bobzien will join on Aug. 8, 2022.
“We are very pleased to welcome Brice and Reyna to our expanded leadership team as we continue to execute upon our vision of building iRhythm into a market leader in the digital healthcare space,” iRhythm President and CEO Quentin Blackford said in a news release.
Bobzien, who will oversee all financial operations of the company and look to advance the culture of operational excellence and prepare the company for future growth, most recently served as SVP of finance and investor relations at continuous glucose monitor maker Dexcom. He joins Blackford, who left Dexcom in September of 2021, as well as Chad Patterson, whose appointment as iRhythm’s CCO was announced last week, as executives from the diabetes technology developer who made the switch to iRhythm.
In total, Bobzien holds more than 20 years of experience and increasing responsibility at leading medical device companies, including Zimmer Holdings and NuVasive, along with Dexcom. He will take over for Douglas Devine, who had been serving as CFO and COO, and will continue on as just COO.
“Brice is a veteran executive who brings a wealth of experience building finance teams and guiding organizations through operational transformations,” Blackford said. “His focus on operational excellence with a disciplined and rigorous approach to financial management and strategic development will position us well for the future. With the addition of Brice into the CFO role, this will allow Doug to focus on the continued improvement of our operational functions that he will continue to lead.”
Fernandez will lead the development and implementation of human resources strategies in support of iRhythm’s global expansion plans, the company said.
She was most recently CHRO at Intersect ENT, which was acquired for $1.1 billion earlier this year by Medtronic. Before Intersect ENT, she held roles at Endologix, Canon Medical Systems, Johnson & Johnson and Bristol-Myers Squibb.
“Reyna is a seasoned HR executive with over 25 years of experience in building human resource teams, implementing talent development programs, and transforming organizations to operate strategically, globally and efficiently,” Blackford said. “We look forward to these two successful individuals joining our team to help lead the organization through significant growth with a focus on operational effectiveness and efficiency.”
Truist analysts said iRhythm’s management team continues to take shape: “We view the strengthening of iRhythm’s leadership team as a positive, especially at a time as the company is poised to move past the reimbursement uncertainty that has been an overhang over the past several years, and shift its focus toward expanding into meaningful growth opportunities that lay ahead.”
